LL

Larry Lasky

Partner at The Column Group

Sausalito, California

Overview

Work Experience

  • Partner

    2014 - Current

    I will continue to invest in early stage therapeutic biotech companies focused on severe diseases. I have made investments in eFFector Pharmaceuticals and was a co-founder of Ribon therapeutics.

  • Partner

    2008 - 2014

    Leader of biotech investment area. Invested in Intellikine (acquired by Takeda/MLNM), founding or co-founding investor of Calithera Pharmaceuticals, Cleave Biosciences and eFFector Pharmaceuticals. Founding investor of Proteolix (acquired by Onyx) and Oncomed (Nasdaq: OMED).

  • Lecturer

    2006 - 2012

    Taught biotechnology entrepreneurship course.

  • General Partner

    2002 - 2008

    Founding partner. Founding investor of several successful companies including Cellective (acquired by Medimmune), Proteolix (acquired by Onyx) and Oncomed (Nasdaq: OMED).

  • Scientist, Senior Scientist, Staff Scientist, Genentech Fellow

    1982 - 2002

    Genentech Fellow is the highest scientific position in the company. There have been 3 Genentech Research Fellows in the history of the company.

  • Senior Scientist

    1981 - 1982

    Founding scientist. Initiated the GM CSF and bone morphogenetic protein projects.

Education

Relevant Websites